Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy

Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy

AbstractBackground Idiopathic membranous nephropathy is widely recognized as an autoimmune kidney disease that is accompanied by the discovery of several autoantibodies, and the antibody subclass in the circulation of patients with iMN is mainly IgG. However, the direct pathogenic effect of the cont...

Full description

Bibliographic Details
Main Authors:	Ying Zhang, Ping Chen, Baobao Wang, Xueqing Tang, Yong Wei, Wei Cao, Lijun Tang, Zunsong Wang, Na Zhao
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Renal Failure
Subjects:	Anti-PLA2R antibody IgG antibody idiopathic membranous nephropathy podocyte injury in vitro
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2023.2271986

Similar Items

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
by: Dóra Bajcsi, et al.
Published: (2023-08-01)

Mitofusin2 expression is associated with podocyte injury in IgA nephropathy
by: Xuanli Tang, et al.
Published: (2023-03-01)

PLA2R-positive membranous nephropathy in IgG4-related disease
by: Yusuke Ushio, et al.
Published: (2024-02-01)

Glomerular IgG deposition predicts kidney disease progression in IgA nephropathy
by: Yue Xing, et al.
Published: (2024-04-01)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
by: Yan-jiao Cheng, et al.
Published: (2023-03-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)

Natural history and pathogenesis of IgG4-related disease
by: Culver, E
Published: (2015)

The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China
by: Hongxia Guo, et al.
Published: (2023-12-01)

Podocytes are likely the therapeutic target of IgA nephropathy with isolated hematuria: Evidence from repeat renal biopsy
by: Mian-Na Luo, et al.
Published: (2023-04-01)

Exploring the depths of IgG4: insights into autoimmunity and novel treatments
by: Selen Ünlü, et al.
Published: (2024-04-01)

Pitfalls in the Serological Diagnosis of Primary Human Cytomegalovirus Infection in Pregnancy Due to Different Kinetics of IgM Clearance and IgG Avidity Index Maturation
by: Antonella Sarasini, et al.
Published: (2021-02-01)

Kinetics IgM and IgG SARS-CoV-2 in Recovery patients with Negative Evaluation RT-PCR
by: Jusup Endang, et al.
Published: (2023-11-01)

PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study
by: Yiqing Huang, et al.
Published: (2022-10-01)

Plasmodium falciparum and Helminth Coinfections Increase IgE and Parasite-Specific IgG Responses
by: Rebeca Santano, et al.
Published: (2021-12-01)

Correlation between the IgG/IgA Antibody Response against PEDV Structural Protein and Virus Neutralization
by: Xu Song, et al.
Published: (2023-06-01)

Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
by: Anita Siller, et al.
Published: (2024-03-01)

Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions
by: Pin-Kuang Lai, et al.
Published: (2021-01-01)

Minimal B Cell Extrinsic IgG Glycan Modifications of Pro- and Anti-Inflammatory IgG Preparations in vivo
by: Anja Schaffert, et al.
Published: (2020-01-01)

Antileishmanial IgG and IgE antibodies recognize predominantly carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis
by: AM Atta, et al.
Published: (2004-08-01)

IgE and IgG4 antibodies in subjects reinfected with Schistosoma mansoni in an endemic area of Northeast Brazil
by: Yara M Gomes, et al.
Published: (1998-01-01)

Clinical and laboratory evaluation of Turkish children with IgG subclass deficiency
by: Mehmet Kocaoğlu, et al.
Published: (2023-01-01)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
by: Bihua Wang, et al.
Published: (2022-09-01)

Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
by: Francesca Zanoni, et al.
Published: (2023-08-01)

Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis
by: Daoyuan Lv, et al.
Published: (2022-05-01)

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations
by: Marjahan Akhtar, et al.
Published: (2023-12-01)

A Survey of Vaccine-Induced Measles IgG Antibody Titer to Verify Temporal Changes in Response to Measles Vaccination in Young Adults
by: Hiraku Sasaki, et al.
Published: (2019-09-01)

IgG Fc Glycosylation Patterns of Preterm Infants Differ With Gestational Age
by: Nele Twisselmann, et al.
Published: (2019-01-01)

Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients
by: Jennifer Schieber, et al.
Published: (2023-04-01)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
by: Olga Lesya Kukuy, et al.
Published: (2023-05-01)

The Blood of the HIV-Infected Patients Contains κ-IgG, λ-IgG, and Bispecific κλ-IgG, Which Possess DNase and Amylolytic Activity
by: Anna Timofeeva, et al.
Published: (2022-02-01)

Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection
by: Sonia Fernandez, et al.
Published: (2013-08-01)

IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review
by: Chang Yang, et al.
Published: (2023-01-01)

Impact of IgG subclass on molecular properties of monoclonal antibodies
by: Yu Tang, et al.
Published: (2021-01-01)

Factors affecting IgG4-mediated complement activation
by: Nienke Oskam, et al.
Published: (2023-01-01)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
by: Yang Chen, et al.
Published: (2023-12-01)

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
by: Jana Sophia Buhre, et al.
Published: (2023-01-01)

Impact of structural modifications of IgG antibodies on effector functions
by: Timon Damelang, et al.
Published: (2024-01-01)

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects
by: Xiandeng Li, et al.
Published: (2023-12-01)

Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy
by: Wang T, et al.
Published: (2019-09-01)

Idiopathic Multicentric Castleman Disease with Strikingly Elevated IgG4 Concentration in the Serum and Abundant IgG4-Positive Cells in the Tissue: A Case Report
by: Chia-Chun Cheng, et al.
Published: (2022-09-01)